Chaoju Eye Care Revamps Company Secretary Roles and Seeks New Listing Rules Waiver

Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) has shared an announcement.

Chaoju Eye Care Holdings has announced a reshuffle of its corporate governance and compliance functions, with joint company secretary and authorised representative Mr. Cheng Ching Kit resigning from his roles, including as process agent, effective 1 January 2026. The company has appointed governance professional Mr. Lo Wai Kin Kent as company secretary, authorised representative and process agent from the same date, leveraging his more than 10 years’ experience in company secretarial and corporate governance work and his professional qualifications in Hong Kong, the UK and Australia. In tandem, joint company secretary Mr. Zhang Guangdi has also resigned because an existing waiver from Hong Kong Listing Rules 3.28 and 8.17 required him to be assisted by Mr. Cheng; Chaoju has applied to the Stock Exchange for a new waiver so that Mr. Zhang can be reappointed, and will make a further announcement once this is granted, underscoring the company’s focus on maintaining regulatory compliance amid changes in key governance personnel.

The most recent analyst rating on (HK:2219) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.

More about Chaoju Eye Care Holdings Ltd.

Chaoju Eye Care Holdings Limited is a Hong Kong-listed ophthalmic medical group incorporated in the Cayman Islands, operating through subsidiaries under stock code 2219. The group focuses on eye care services and related medical treatments in mainland China, positioning itself within the specialised healthcare and eye-care services sector.

Average Trading Volume: 473,416

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.95B

Find detailed analytics on 2219 stock on TipRanks’ Stock Analysis page.